BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23199209)

  • 1. Complement activation in astrocytomas: deposition of C4d and patient outcome.
    Mäkelä K; Helén P; Haapasalo H; Paavonen T
    BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.
    Mäkelä K; Nordfors K; Finne J; Jokilammi A; Paavonen T; Haapasalo H; Korja M; Haapasalo J
    BMC Cancer; 2014 Aug; 14():623. PubMed ID: 25164322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.
    Valkonen M; Haapasalo H; Rilla K; Tyynelä-Korhonen K; Soini Y; Pasonen-Seppänen S
    BMC Cancer; 2018 Jun; 18(1):664. PubMed ID: 29914429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
    Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
    Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
    Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
    Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins.
    Camby I; Nagy N; Lopes MB; Schäfer BW; Maurage CA; Ruchoux MM; Murmann P; Pochet R; Heizmann CW; Brotchi J; Salmon I; Kiss R; Decaestecker C
    Brain Pathol; 1999 Jan; 9(1):1-19. PubMed ID: 9989446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.
    Ding Y; Yu X; Wu L; Tan Y; Qu Z; Yu F
    Front Immunol; 2021; 12():654652. PubMed ID: 34276649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
    Abd El-Hafez A; Ismail Hany HSED
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
    Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):275-81. PubMed ID: 11895042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of C4d deposition in the follicular lymphoma].
    Zheng ZY; Bu XM; Wang C; Xiong XS; Wu ZZ; Yu YH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):227-9. PubMed ID: 17877197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.